Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
national
3
×
national blog main
national top stories
raleigh-durham blog main
san francisco blog main
biotech
boston top stories
boulder/denver blog main
cancer
detroit blog main
indiana blog main
life sciences
new york blog main
novartis
raleigh-durham top stories
san diego blog main
san francisco top stories
seattle blog main
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
abbvie
accent therapeutics
actavalon
acute myeloid leukemia
aducanumab
aileron therapeutics
alzheimer's disease
amblyotech
aprea therapeutics
arimoclomol
arnold levine
asklepios biopharmaceutical
baker brothers
bioeurope
biogen
biomarin pharmaceutical
What
developing
3
×
company
investors
ipo
activity
approvals
bio
biogen
blood
broader
business
cancer
clamped
comes
control
covid
delays
detect
economic
effect
execs
external
factors
fast
fda
files
firms
founders
grail
immigration
including
innovation
intended
isn’t
join
leaders
life
lot
medicines
new
Language
unset
Current search:
national
×
developing
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation